Zobrazeno 1 - 10
of 17
pro vyhledávání: '"Ivana Casaroli"'
Autor:
Guido Bocci, Sabrina Pelliccia, Paola Orlandi, Matteo Caridi, Marta Banchi, Gerardo Musuraca, Arianna Di Napoli, Maria Paola Bianchi, Caterina Patti, Paola Anticoli-Borza, Roberta Battistini, Ivana Casaroli, Tiziana Lanzolla, Agostino Tafuri, Maria Christina Cox
Publikováno v:
Journal of Clinical Medicine; Volume 11; Issue 23; Pages: 7162
The upfront treatment of very elderly and frail patients with diffuse large B-cell lymphoma (DLBCL) is still a matter of debate. Herein, we report results of the metronomic all-oral DEVEC [prednisolone/deltacortene®, vinorelbine (VNR), etoposide (ET
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::87228d38960f0cc851272f9a4b0053bc
https://pubmed.ncbi.nlm.nih.gov/36498736
https://pubmed.ncbi.nlm.nih.gov/36498736
Autor:
Simone Ferrero, Daniele Grimaldi, Elisa Genuardi, Daniela Drandi, Gian Maria Zaccaria, Beatrice Alessandria, Marco Ghislieri, Martina Ferrante, Andrea Evangelista, Barbara Mantoan, Gabriele De Luca, Piero Maria Stefani, Fabio Benedetti, Ivana Casaroli, Manuela Zanni, Claudia Castellino, Vincenzo Pavone, Mario Petrini, Francesca Re, Stefan Hohaus, Gerardo Musuraca, Nicola Cascavilla, Chiara Ghiggi, Anna Marina Liberati, Sergio Cortelazzo, Marco Ladetto
Minimal residual disease (MRD) analysis is a known predictive tool in mantle cell lymphoma (MCL). We describe MRD results from the Fondazione Italiana Linfomi phase 3 MCL0208 prospective clinical trial assessing lenalidomide (LEN) maintenance vs obse
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bb0dd91a41f76f65c318bc7694118dc8
https://hdl.handle.net/11589/250825
https://hdl.handle.net/11589/250825
Autor:
Manuela Zanni, Pietro Maria Stefani, Simone Ferrero, Caterina Stelitano, Riccardo Moia, Luciano Cascione, Michael Mian, Gianluca Gaidano, Beatrice Alessandria, Daniele Grimaldi, Sara Galimberti, Ivana Casaroli, Mattia Schipani, Chiara Favini, Davide Rossi, Gian Maria Zaccaria, Vincenzo Pavone, C. Castellino, Andrea Rinaldi, Franco Narni, Andrea Evangelista, Francesco Bertoni, Sergio Cortelazzo, Francesca Re, Fabio Benedetti, M. Ladetto
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6dc4cd9cda5380d312ef423779464df8
https://hdl.handle.net/11589/250889
https://hdl.handle.net/11589/250889
Autor:
Caterina Stelitano, Benedetta Puccini, Manuela Zanni, Luca Arcaini, Rita Tavarozzi, Michael Mian, Umberto Vitolo, Sergio Cortelazzo, Federica Cavallo, Piero Maria Stefani, Monica Balzarotti, Anna Lia Molinari, Giovannino Ciccone, Chiara Pagani, Maria Gomes da Silva, Alessandro Re, Ivana Casaroli, Maurizio Martelli, Filippo Ballerini, Simone Ferrero, Marco Ladetto, Annalisa Chiappella, Vittorio Stefoni, Vittorio Ruggero Zilioli, Alice Di Rocco, Andrea Evangelista, Franco Narni, Andrés J.M. Ferreri, Fabio Benedetti
Publikováno v:
The Lancet. Haematology. 8(1)
Summary Background Fit patients with mantle cell lymphoma aged 18–65 years are usually given cytarabine and rituximab-based induction regimens followed by autologous haematopoetic stem-cell transplantation (HSCT). We investigated whether post-autol
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::873e5c55dff1387f589eefaaceb4738d
https://pubmed.ncbi.nlm.nih.gov/33357479
https://pubmed.ncbi.nlm.nih.gov/33357479
Autor:
Carmelo Carlo-Stella, Rosa Daffini, Luisa Lorenzi, Fabrizio Marino, Alessandra Tucci, Paolo Corradini, Alessandro Re, Fabio Facchetti, Giulia Soverini, Giuseppe Rossi, Chiara Pagani, Piera Balzarini, Anna Guidetti, Ivana Casaroli, Giulia Campostrini, Anna Dodero, Monica Balzarotti
Publikováno v:
Blood. 136:38-39
Introduction: We have previously reported short-term efficacy of six courses of R-DA-EPOCH in patients with aggressive B cell lymphomas carrying concomitant MYC and BCL-2 and/or BCL-6 rearrangement (DHL/THL) or gene increase copy number (ICN) (Tucci
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0e5843893c2b7da48e6ae6cc7f8782ef
https://doi.org/10.1182/blood-2020-139977
https://doi.org/10.1182/blood-2020-139977
Autor:
Guido Bocci, Agostino Tafuri, M. Christina Cox, Ivana Casaroli, Francesca Fabbri, Arianna Di Napoli, Paola Anticoli Borza, Annalisa Arcari, Luigi Marcheselli, Matteo Caridi, Sabrina Pelliccia, Roberta Battistini, Gerardo Musuraca, Caterina Patti, Francesca di Landro
Metronomic-chemotherapy (M-CHT) has been rarely assessed in non-Hodgkin-lymphoma (NHL). Therefore, in 2011 we started experimenting a new all-oral M-CHT schedule termed DEVEC (Deltacortene®, etoposide, vinorelbine, cyclophosphamide, +/-Rituximab) in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::979705c0f1856c3238ba6bd67128a179
http://hdl.handle.net/11573/1280926
http://hdl.handle.net/11573/1280926
Autor:
Maria Christina Cox, Francesca Fabbri, Paola Anticoli-Borza, Guido Bocci, Virginia Naso, Roberta Battistini, Francesco Merli, Gerardo Musuraca, Agostino Tafuri, Ivana Casaroli, Annalisa Arcari, Francesca di Landro, Valerio Zoli
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::43f2c6e2905c518a64538b298b0bdf04
http://hdl.handle.net/11568/881410
http://hdl.handle.net/11568/881410
Autor:
Elisa Genuardi, Claudia Castellino, Giovannino Ciccone, Manuela Zanni, Gerardo Musuraca, Luigia Monitillo, Vincenzo Pavone, Umberto Vitolo, Pietro Maria Stefani, Nicola Cascavilla, Marco Ladetto, Sergio Cortelazzo, Simone Ferrero, Stefan Hohaus, Daniele Grimaldi, Annalisa Cifaratti, Francesca Re, Anna Marina Liberati, Ivana Casaroli, Mario Petrini, Mariella Lo Schirico, Gian Maria Zaccaria, Fabio Benedetti, Andrea Evangelista, Daniela Drandi, Angela Congiu, Barbero Daniela
Publikováno v:
Blood. 132:920-920
Background and Aims. Minimal residual disease (MRD) detection by PCR-based methods is a relevant outcome predictor in MCL, however it is not clear which might represent the most effective methodology (nested vs real-time quantitative PCR, RQ-PCR), th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b0a42ba861cfc3b0840f19b562fb7bc9
https://doi.org/10.1182/blood-2018-99-114442
https://doi.org/10.1182/blood-2018-99-114442
Autor:
Gerardo Musuraca, Agostino Tafuri, Anna Paola Leporace, Sabrina Pelliccia, Francesca Fabbri, Paola Anticoli Borza, Giulia Galassi, Monica Piedimonte, Daniela Prosperi, Guido Bocci, Ivana Casaroli, Valerio Zoli, Roberta Battistini, Francesca di Landro, Annalisa Arcari, Maria Christina Cox, Arianna Di Napoli, Marco di Girolamo, Alessia Campagna
Publikováno v:
Journal of Clinical Oncology. 36:7563-7563
7563Background: Metronomic chemotherapy (MC) is an emerging approach in solid tumours. Since MC has been poorly investigated in aggressive lymphomas in 2011, we formulated a new oral MC regimen ter...
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6f5e3490b856ad048630326afdd03806
https://doi.org/10.1200/jco.2018.36.15_suppl.7563
https://doi.org/10.1200/jco.2018.36.15_suppl.7563
Autor:
Fausto Rossini, Elisa Doni, Angelo Belotti, Ivana Casaroli, Enrico Maria Pogliani, Silvia Bolis, Sara Pezzatti, Pietro Pioltelli
Publikováno v:
Clinical lymphoma, myelomaleukemia. 15(4)
Diffuse large B-cell lymphoma is an aggressive lymphoma and a large number of studies have therefore focused on the search for prognostic factors. The same interest concerns FL, for which identification of patients candidates for watch and wait (WW)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8c1af67b9c2dedf9e12d51c496b48f95
https://pubmed.ncbi.nlm.nih.gov/25468321
https://pubmed.ncbi.nlm.nih.gov/25468321